Heat shock protein 90 (Hsp90); mitogen-activated protein kinase kinase (MEK) BriefCommunication Pages: 919 - 919
Eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1); mammalian target of rapamycin (mTOR; FRAP; RAFT1) BriefCommunication Pages: 921 - 921
Regulator of G-protein signaling 5 (RGS5); MAP kinase kinase 1 (MAP2K1; MEK1); MAP kinase 3 (MAPK3; ERK-1); MAPK1 (ERK-2) BriefCommunication Pages: 922 - 922
Hematopoietic prostaglandin D2 (PGD2); hematopoietic prostaglandin D2 synthase (HPGDS) BriefCommunication Pages: 927 - 927
Computational model to predict in vitro fertilization (IVF) success BriefCommunication Pages: 930 - 930
Improved mouse model for studying Duchenne muscular dystrophy (DMD) BriefCommunication Pages: 931 - 931
Influenza A virus hemagglutinin (HA) DNA–based vaccines for broad influenza prevention BriefCommunication Pages: 933 - 933
Addition of N-acetylneuraminic acid (Neu5Ac) to culture media for producing recombinant therapeutic glycoproteins BriefCommunication Pages: 934 - 934
Calcium phosphate bone substitutes as alternatives to autologous bone grafts BriefCommunication Pages: 935 - 935
Gold-coated iron oxide core nanoparticles as multifunctional contrast agents BriefCommunication Pages: 936 - 936
A six-gene signature involving Krupple-like factor 6 (KLF6; COPEB; ZF9), FBJ murine osteosarcoma viral oncogene homolog B (FOSB), nuclear factor of κ light polypeptide gene enhancer I B-cells inhibitor-ζ (NFKBIZ), ATPase H+/K+ exchanging α-polypeptide (ATP4A), germ cell associated 1 (GSG1) and sialic acid binding Ig-like lectin 11 (SIGLEC11) as pancreatic cancer biomarkers BriefCommunication Pages: 938 - 938
K-Ras (KRAS) as a biomarker for mammalian target of rapamycin (mTOR; FRAP; RAFT1) inhibitor treatment BriefCommunication Pages: 939 - 939